Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William D Fisher

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Canadian Journal of Surgery. Journal Canadien De Chirurgie|July 22, 2011
Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplastyWilliam D Fisher
Canadian Journal of Surgery. Journal Canadien De Chirurgie|March 23, 2013
Hepatitis C and the surgeonWilliam D Fisher
The American Journal of Managed Care|April 27, 2011
New oral anticoagulants and outpatient prophylaxis of venous thromboembolismWilliam D Fisher
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 4, 2008
Outpatient thromboprophylaxis after hip or knee surgery: discrepancies and concernsWilliam D Fisher, Alexander G G Turpie
BMC Musculoskeletal Disorders|February 20, 2016
Aggrecan heterogeneity in articular cartilage from patients with osteoarthritisJohn S Mort, Yeqing Geng, William D Fisher, et al.
Clinical Therapeutics|October 21, 2015
Trends in Prescribing Oral Anticoagulants in Canada, 2008-2014Jeffrey I Weitz, William Semchuk, Alexander G G Turpie, et al.
Thrombosis and Haemostasis|January 10, 2009
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)Alexander G G Turpie, Kenneth A Bauer, Bruce L Davidson, et al.
Thrombosis and Haemostasis|June 6, 2007
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studiesWilliam D Fisher, Bengt I Eriksson, Kenneth A Bauer, et al.
Lancet (London, England)|May 5, 2009
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trialAlexander G G Turpie, Michael R Lassen, Bruce L Davidson, et al.
Clinical Pharmacokinetics|March 1, 2008
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgeryWolfgang Mueck, Bengt I Eriksson, Kenneth A Bauer, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Canadian Journal of Surgery. Journal Canadien De Chirurgie|July 22, 2011
Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplastyWilliam D Fisher
Canadian Journal of Surgery. Journal Canadien De Chirurgie|March 23, 2013
Hepatitis C and the surgeonWilliam D Fisher
The American Journal of Managed Care|April 27, 2011
New oral anticoagulants and outpatient prophylaxis of venous thromboembolismWilliam D Fisher
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 4, 2008
Outpatient thromboprophylaxis after hip or knee surgery: discrepancies and concernsWilliam D Fisher, Alexander G G Turpie
BMC Musculoskeletal Disorders|February 20, 2016
Aggrecan heterogeneity in articular cartilage from patients with osteoarthritisJohn S Mort, Yeqing Geng, William D Fisher, et al.
Clinical Therapeutics|October 21, 2015
Trends in Prescribing Oral Anticoagulants in Canada, 2008-2014Jeffrey I Weitz, William Semchuk, Alexander G G Turpie, et al.
Thrombosis and Haemostasis|January 10, 2009
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)Alexander G G Turpie, Kenneth A Bauer, Bruce L Davidson, et al.
Thrombosis and Haemostasis|June 6, 2007
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studiesWilliam D Fisher, Bengt I Eriksson, Kenneth A Bauer, et al.
Lancet (London, England)|May 5, 2009
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trialAlexander G G Turpie, Michael R Lassen, Bruce L Davidson, et al.
Clinical Pharmacokinetics|March 1, 2008
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgeryWolfgang Mueck, Bengt I Eriksson, Kenneth A Bauer, et al.
Pageof 1